Shares slid 6.8% to $34.90 as technical analysts flagged a descending triangle — a chart pattern often signaling further downside — just as a widening salmonella outbreak revived food-safety fears that have dogged the chain before. The selloff stands out because broader markets and consumer discretionary stocks rose on the same day, pointing to a crisis of confidence specific to Chipotle.
A Strong Quarter Wasn't Enough to Hold the Rally
Just last week, Chipotle reported Q2 revenue up 9.3% to $3.35 billion, with same-store sales rising 2.2% on a 1% traffic increase.
The company raised its full-year comparable-sales outlook to low-single-digit growth, up from flat. Shares jumped 12% the day after earnings. But the post-earnings pop is now completely erased, illustrating how quickly sentiment can reverse when a technical pattern meets a food-safety headline.
A 345-Person Outbreak Reopens Old Wounds
The CDC reports 345 salmonella cases across 27 states, with 36 hospitalizations.
Of 191 people interviewed, 93% ate at a Mexican-style restaurant — including Chipotle — before falling ill.
Chipotle switched jalapeño suppliers on July 20 and says it is no longer serving affected product. Yet the damage to sentiment echoes the 2015 E. coli crisis that cut Chipotle's stock price roughly in half over several months. Investors are weighing whether history repeats.
Valuation Is Stretched Relative to Peers — but Cheap by Chipotle's Own Standards
The stock carries a P/E (price divided by earnings) of roughly 34.5 times — meaning investors pay about $34.50 for every dollar of annual profit. That's still above the S&P 500 average of roughly 24 times, fueling the "stretched" call by technicians. But the multiple sits 46% below Chipotle's own 10-year median of about 64 times, suggesting the premium has already been squeezed hard.
Margin Pressure Gives Bears Real Ammunition
Operating margin fell to 15.7% in Q2, down from 18.2% a year ago,
squeezed by higher beef and freight costs and rising wages. With management guiding for margin recovery only in Q4, shareholders face at least one more quarter of profit compression — right as the outbreak may dent near-term traffic. Wall Street's consensus target remains $44.05, implying about 30% upside, but that math depends on the food-safety scare fading fast and costs easing on schedule.